GlassScriptPhysician profile
Daniel B Merritt
NPI 1548237738
$3,838.58
in general payments reported to CMS, 2019-2025
37 companies · $1,017 in 2025
The $1,017 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $90.65 · 2021: $181 · 2022: $702 · 2023: $780 · 2024: $774 · 2025: $1,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,570.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $317.25 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Pacira Pharmaceuticals Incorporated | $256.75 | 2021-2024 | Exparel |
| Intuitive Surgical, INC. | $248.54 | 2019-2023 | Da Vinci Surgical System |
| Ethicon US, LLC | $241.85 | 2022-2025 | Echelon Flex, Ethicon, Enseal |
| Davol INC. | $230.89 | 2020-2025 | Phasix Mesh |
| Acera Surgical, INC. | $228.22 | 2023-2025 | Restrata Wound Matrix |
| Vertex Pharmaceuticals Incorporated | $206.76 | 2024-2025 | |
| Polynovo North America LLC | $197.82 | 2024-2025 | Novosorb Btm |
| Medtronic, INC. | $172.05 | 2022-2025 | Penditure, Progrip, Signia |
| Astrazeneca Pharmaceuticals LP | $161.87 | 2023-2024 | |
| My01 INC. | $143.16 | 2022 | |
| Stryker Corporation | $136.80 | 2025 | Spy-Phi System |
| Solventum Corporation | $131.54 | 2024 | |
| Octapharma USA, INC. | $125.93 | 2025 | Fibryga |
| Acell, INC. | $124.46 | 2019 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $118.80 | 2025 | |
| Tela Bio, INC. | $109.35 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Shockwave Medical, INC | $99.89 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Heron Therapeutics, INC. | $77.29 | 2021-2025 | Zynrelef |
| Angiodynamics, INC. | $53.29 | 2025 | Angiovac |
| Silk Road Medical, INC. | $47.62 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Lsi Solutions INC | $47.43 | 2022 | |
| Cvrx, INC. | $39.87 | 2025 | Barostim Neo System |
| W. L. Gore & Associates, INC. | $37.55 | 2022 | |
| Corcym INC | $35.29 | 2023 | Perceval |
| Medtronic USA, INC. | $32.00 | 2019 | |
| Lexington Medical, INC. | $27.95 | 2021 | |
| Endomagnetics LTD | $26.01 | 2023 | Magtrace, Magseed |
| Trevena, INC. | $24.36 | 2022 | |
| Kci USA, INC. | $22.40 | 2019 | |
| Edwards Lifesciences Corporation | $19.84 | 2024 | Mitris Resilia Mitral Valve |
| Innovation Technologies INC | $19.17 | 2022 | |
| Teleflex LLC | $18.21 | 2022 | |
| Mimedx Group, INC. | $16.39 | 2024 | |
| Pylant Medical | $14.53 | 2022 | |
| Hologic Sales and Service, LLC | $14.15 | 2025 | Coolseal Generator |
| Thd America, INC. | $13.30 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Merritt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.